TITLE

Pharmacology Update: Fantanyl Sublingual Tablets (Abstral) CII

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
February 2011
SOURCE
Internal Medicine Alert;2/15/2011, Vol. 33 Issue 3, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers pharmacology update about the formulation of the U.S. Food and Drug Administration (FDA)-approved fentanyl sublingual tablets to alleviate pain in cancer patients.
ACCESSION #
59522680

 

Related Articles

  • The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study. Do-Yeun Kim; Hong-Suk Song; Jin-Seok Ahn; Baek-Yeol Ryoo; Dong-Bok Shin; Chang-Yeol Yim; Si-Young Kim // Supportive Care in Cancer;Feb2010, Vol. 19 Issue 2, p297 

    Background: End-of-dose failure is commonly observed as therapeutic levels of sustained-release opioids fall. However, little is known about using these medications for cancer pain control. To determine the dosing frequency of sustained-release opioids (morphine, oxycodone, and transdermal...

  • Breast cancer pain needs not being met.  // Independent Nurse;12/5/2011, p7 

    The article reports that 34% of women with secondary breast cancer in Great Britain are living in needless pain, with less than one in 10 visiting their general practice regularly, according to a Breast Cancer Care study of 253 patients as of December 2011.

  • Hypnosis and Breast Surgery Patients.  // IDEA Fitness Journal;Jan2008, Vol. 5 Issue 1, p90 

    The article focuses on the result of a study which examined the use of hypnosis in breast surgery patients, published in the 2007 issue of the "Journal of the National Cancer Institute." The study concluded that breast surgery patients who received hypnosis before surgery needed less pain...

  • The Use of Massage Therapy for Reducing Pain, Anxiety, and Depression in Oncological Palliative Care Patients: A Narrative Review of the Literature. Falkensteiner, Maria; Mantovan, Franco; Müller, Irene; Them, Christa // ISRN Nursing;2011, Special section p1 

    A considerable number of cancer patients use complementary medicine therapies in order to alleviate different symptoms such as pain, anxiety, and depression, occurring in connection with cancer. This paper explores the question to what extent massage therapies are able to reduce the amount of...

  • Le rôle de l'ergothérapie dans la prévention et le traitement de la douleur associée au cancer. Lapointe, Julie // Occupational Therapy Now;Sep2012, Vol. 14 Issue 5, p10 

    No abstract available.

  • Get the Basics on End-of-Life Medications. RICHARDSON, PAMELA // ONS Connect;Jun2015, Vol. 30 Issue 2, p45 

    The article focuses on the basics of end-of-life (EOL) medications. Topics discussed include treatment of EOL cancer pain with nonsteroidals and opioids, EOL nursing care including familiar pain assessment process, sign of discomfort being dyspnea, relieving anxiety through benzodiazepines and...

  • Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report. Kwon, Jung; Oh, Sung; Chisholm, Gary; Lee, Jung-Ae; Lee, Jae; Park, Keon; Nam, Seung-Hyun; Song, Hun; Lee, Keehyun; Zang, Dae; Kim, Ho; Choi, Dae; Kim, Hyo; Kim, Jung; Jung, Joo; Jang, Geundoo; Kim, Hyeong; Won, Ji; Bruera, Eduardo // Supportive Care in Cancer;Apr2013, Vol. 21 Issue 4, p1175 

    Purpose: Pain is one of the most common and devastating symptoms in cancer patients, and misunderstandings on the patient's part can cause major obstacles in pain management. Method: We evaluated factors associated with patient's high barrier score to managing cancer-associated pain by having...

  • Fentanyl buccal tablet improves QOL in cancer patients with breakthrough pain.  // PharmacoEconomics & Outcomes News;9/29/2012, Issue 663, p10 

    The article discusses a study in Europe which found that quality of life (QOL) of patients with cancer is improved by fentanyl buccal tablet.

  • Spray improved pain management in cancer patients.  // Hem/Onc Today;5/25/2013, Vol. 14 Issue 10, p56 

    The article discusses the findings of a randomized study which revealed the therapeutic use of fentanyl sublingual spray in improving a number of pain and adverse event categories in a cohort of patients with several types of cancer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics